Golestan University of Medical Sciences Repository

Items where Author is "Ahmadinejad, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 3.

Abolghasemi, H. and Panahi, Y. and Ahmadinejad, M. and Toogeh, G. and Karimi, M. and Eghbali, A. and Mirbehbahani, N.B. and Dehdezi, B.K. and Badiee, Z. and Hoorfar, H. and Eshghi, P. and Maghsoudi, N. and Sahebkar, A. and Gholami-Fesharaki, M. (2018) Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients. Journal of Pharmacopuncture, 21 (2). pp. 76-81.

Faranoush, M. and Abolghasemi, H. and Mahboudi, F. and Toogeh, G. and Karimi, M. and Eshghi, P. and Managhchi, M. and Hoorfar, H. and Dehdezi, B.K. and Mehrvar, A. and Khoeiny, B. and Vaziri, B. and Kamyar, K. and Heshmat, R. and Baghaeipour, M.R. and Mirbehbahani, N.B. and Fayazfar, R. and Ahmadinejad, M. and Naderi, M. (2016) A comparison of efficacy between recombinant activated factor VII (Aryoseven) and Novoseven in patients with hereditary FVIII deficiency with inhibitor. Clinical and Applied Thrombosis/Hemostasis, 22 (2). pp. 184-190. ISSN 19382723

Faranoush, M. and Abolghasemi, H. and Toogeh, G. and Karimi, M. and Eshghi, P. and Managhchi, M. and Hoorfar, H. and Dehdezi, B.K. and Mehrvar, A. and Khoeiny, B. and Kamyar, K. and Heshmat, R. and Baghaeipour, M.R. and Mirbehbahani, N.B. and Fayazfar, R. and Ahmadinejad, M. and Naderi, M. (2015) A Comparison between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients with Congenital Factor VII Deficiency. Clinical and Applied Thrombosis/Hemostasis, 21 (8). pp. 724-728.

This list was generated on Mon Sep 23 02:37:16 2019 IRST.